Showing 1 - 8 results of 8 for search 'Guy L Odom', query time: 0.04s Refine Results
  1. 1
    Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effects.

    Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effects. by Glen B Banks, Jeffrey S Chamberlain, Guy L Odom

    Published 2020-11-01
    Get full text
    Article
  2. 2
    Muscle structure influences utrophin expression in mdx mice.

    Muscle structure influences utrophin expression in mdx mice. by Glen B Banks, Ariana C Combs, Guy L Odom, Robert J Bloch, Jeffrey S Chamberlain

    Published 2014-06-01
    Get full text
    Article
  3. 3
    Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle

    Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle by Marcelo dos Santos Voltani Lorena, Estela Kato dos Santos, Renato Ferretti, G. A. Nagana Gowda, Guy L. Odom, Jeffrey S. Chamberlain, Cintia Yuri Matsumura

    Published 2023-09-01
    Get full text
    Article
  4. 4
    Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy

    Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy by Niclas E. Bengtsson, John K. Hall, Guy L. Odom, Michael P. Phelps, Colin R. Andrus, R. David Hawkins, Stephen D. Hauschka, Joel R. Chamberlain, Jeffrey S. Chamberlain

    Published 2017-02-01
    Get full text
    Article
  5. 5
    Correction: Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy

    Correction: Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy by Niclas E. Bengtsson, John K. Hall, Guy L. Odom, Michael P. Phelps, Colin R. Andrus, R. David Hawkins, Stephen D. Hauschka, Joel R. Chamberlain, Jeffrey S. Chamberlain

    Published 2017-06-01
    Get full text
    Article
  6. 6
    Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model

    Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model by Zachary M. Howard, Lisa E. Dorn, Jeovanna Lowe, Megan D. Gertzen, Pierce Ciccone, Neha Rastogi, Guy L. Odom, Federica Accornero, Jeffrey S. Chamberlain, Jill A. Rafael-Fortney

    Published 2021-04-01
    Get full text
    Article
  7. 7
    Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model

    Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model by Arden B. Piepho, Jeovanna Lowe, Laurel R. Cumby, Lisa E. Dorn, Dana M. Lake, Neha Rastogi, Megan D. Gertzen, Sarah L. Sturgill, Guy L. Odom, Mark T. Ziolo, Federica Accornero, Jeffrey S. Chamberlain, Jill A. Rafael-Fortney

    Published 2023-03-01
    Get full text
    Article
  8. 8
    Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate

    Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate by Stephen C. Kolwicz, Jr., PhD, John K. Hall, PhD, Farid Moussavi-Harami, MD, Xiolan Chen, PhD, Stephen D. Hauschka, PhD, Jeffrey S. Chamberlain, PhD, Michael Regnier, PhD, Guy L. Odom, PhD

    Published 2019-11-01
    Get full text
    Article

Search Tools: